ENDEFR
Home › Switzerland › Kavis Pharma Holding B.V.

Kavis Pharma Holding B.V.

besloten vennootschap met beperkte aansprakelijkheid (BV) · Küssnacht am Rigi, Switzerland · LEI 724500SXIULP5HFZKY50
LEI active

Summary

Kavis Pharma Holding B.V. is registered in the Netherlands and entered in the “Business Register (KvK)” under number 89332741. Its legal form is besloten vennootschap met beperkte aansprakelijkheid (BV) – private limited company (Netherlands). According to GLEIF, its ultimate parent is Extrovis AG (Switzerland), which is also its direct parent. That group has 1 subsidiary with LEIs in 1 country, 1 of them in Switzerland. The LEI was first issued on 27 Nov 2025 and the record was last updated on 17 Aug 2026; the next renewal is due by 27 Nov 2026. AssetCensus found 1 data-quality note for this entity (see below).

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

  • The ultimate-parent link rests on accounts for the period ending 31 Dec 2023, more than 24 months before this data release. The group may have changed since.

Company details

Legal formbesloten vennootschap met beperkte aansprakelijkheid (BV)
private limited company (Netherlands)
RegisterBusiness Register (KvK) · Register website
Registration number89332741
Registration authorityThe Netherlands Chamber of Commerce
JurisdictionNetherlands
Registered addressLindenweg 1, 6403 Küssnacht am Rigi, Switzerland
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)20 Feb 2023
LEI724500SXIULP5HFZKY50
LEI statusactive
LEI first issued27 Nov 2025
LEI record last updated17 Aug 2026
Next LEI renewal27 Nov 2026
Corroboration of the LEI recordfully corroborated

Group membership

Extrovis AG Switzerland ultimate parent
Kavis Pharma Holding B.V. this entity

Relationship to the parent

Direct parentUltimate parent
ParentExtrovis AGExtrovis AG
Accounting period1 Jan 2023 to 31 Dec 20231 Jan 2023 to 31 Dec 2023
Evidenceconsolidated accountsconsolidated accounts
Corroborationfully corroboratedfully corroborated
Accounting standardIFRSIFRS
Consolidation percentage reported to GLEIF100.00%100.00%
Relationship start24 Feb 202324 Feb 2023
Recorded at GLEIF since27 Nov 202527 Nov 2025
Last updated27 Nov 202527 Nov 2025
Record statuscurrentcurrent

History

17 Aug 2026Registered address changed
17 Aug 2026Headquarters address changed